BMJ  2005;331:706-707 (1 October), doi:10.1136/bmj.331.7519.706

Editorial

Antimalarial treatment with artemisinin combination therapy in Africa

Desirable, achievable, but not easy

The first 150 words of the full text of this article appear below.

The steady increase of drug resistant malaria across Africa is a crisis for which there are achievable solutions, but no easy ones. The scale of the problem is not in doubt. In Africa malaria remains one of the commonest causes of death and serious morbidity, especially for children and pregnant women.1 Despite a decision in principle by many countries in Africa to use artemisinin based combination therapies (ACTs), most cases of malaria are still treated with monotherapy and in many areas most of these treatments will fail.2 3

Drug combinations, rather than monotherapy, are now seen to be the best solution for treating malaria, and artemisinin based drug combinations are highly effective, with cure rates similar to that of chloroquine 30 years ago. They seem to be a good long term choice for most African countries, being safe and well tolerated (with the caveat that their safety in early pregnancy . . . [Full text of this article]

Grace Malenga, director

Malaria Alert Centre, Bantyre, Malawi

Ayo Palmer, director

Centre for Innovation Against Malaria, Banjul, The Gambia

Sarah Staedke, adjunct assistant professor

Makerere University-UCSF Malaria Research Collaboration, PO Box 7475, Kampala, Uganda

Walter Kazadi, policy adviser, West African Network for Monitoring Antimalarial Treatment II

Malaria Consortium, Accra, Ghana

Theonest Mutabingwa, chairman, East African Network for Monitoring Antimalarial Treatment

Muheza Designated District Hospital, Muheza, Tanga Region, Tanzania

Evelyn Ansah, district director of health services

Dangme West District Health Directorate/Research Centre, PO Box 1, Dodowa, Ghana

Karen I Barnes, associate professor

Division of Clinical Pharmacology, University of Cape Town, South Africa

Christopher JM Whitty, senior lecturer

Gates Malaria Partnership, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1B 3DP (c.whitty@lshtm.ac.uk)


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Relevant Articles

Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study
Dejan Zurovac, Mickey Ndhlovu, Alexander K Rowe, Davidson H Hamer, Donald M Thea, and Robert W Snow
BMJ 2005 331: 734. [Abstract] [Full Text] [PDF]

Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study
Hugh Reyburn, Redepmta Mbatia, Chris Drakeley, Ilona Carneiro, Emmanuel Mwakasungula, Ombeni Mwerinde, Kapalala Saganda, John Shao, Andrew Kitua, Raimos Olomi, Brian M Greenwood, and Christopher J M Whitty
BMJ 2004 329: 1212. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • del Pilar Crespo, M., Avery, T. D., Hanssen, E., Fox, E., Robinson, T. V., Valente, P., Taylor, D. K., Tilley, L. (2008). Artemisinin and a Series of Novel Endoperoxide Antimalarials Exert Early Effects on Digestive Vacuole Morphology. Antimicrob. Agents Chemother. 52: 98-109 [Abstract] [Full text]  
  • GUTHMANN, J.-P., COHUET, S., RIGUTTO, C., FORTES, F., SARAIVA, N., KIGULI, J., KYOMUHENDO, J., FRANCIS, M., NOEL, F., MULEMBA, M., BALKAN, S. (2006). High efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in caala, central angola.. Am J Trop Med Hyg 75: 143-145 [Abstract] [Full text]  
  • MAKANGA, M., PREMJI, Z., FALADE, C., KARBWANG, J., MUELLER, E. A., ANDRIANO, K., HUNT, P., DE PALACIOS, P. I. (2006). EFFICACY AND SAFETY OF THE SIX-DOSE REGIMEN OF ARTEMETHER-LUMEFANTRINE IN PEDIATRICS WITH UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA: A POOLED ANALYSIS OF INDIVIDUAL PATIENT DATA. Am J Trop Med Hyg 74: 991-998 [Abstract] [Full text]  

Rapid Responses:

Read all Rapid Responses

Is advocacy an option for achieving increased access to ACT in Africa?
Mukosha B Chitah
bmj.com, 30 Sep 2005 [Full text]
Need for strategic approach to Malaria resistance
David Kieghe
bmj.com, 5 Oct 2005 [Full text]
Premunition in malaria: let’s look forward to it
Dr. Rajesh Chauhan, et al.
bmj.com, 10 Oct 2005 [Full text]
Is ACT cost really a barrier to implementation?
Catherine M Royce
bmj.com, 22 Nov 2005 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ